Hydronephrosis

Hydronephrosis is the aseptic dilation of the renal pelvis and calyces of one or both kidneys, caused by an accumulation of urine. It typically results from an anatomical or functional obstruction of urine flow out of the kidney, or from vesicoureteral reflux (VUR). If left untreated, the chronic pressure elevation can lead to progressive renal atrophy and irreversible kidney failure.

• Intrinsic Obstruction: Nephrolithiasis (kidney stones), ureteral strictures, blood clots, or transitional cell carcinoma.
• Extrinsic Compression: Benign prostatic hyperplasia (BPH), retroperitoneal fibrosis, pregnancy, pelvic/gynecological malignancies (cervical, ovarian cancer), or uterine fibroids.
• Functional/Congenital: Ureteropelvic junction (UPJ) obstruction, posterior urethral valves, or vesicoureteral reflux (VUR).

Obstruction of urinary outflow increases retrograde hydrostatic pressure within the ureter and renal pelvis. This elevated pressure is transmitted back to the collecting ducts and Bowman’s capsule, reducing the glomerular filtration rate (GFR). Prolonged pressure causes renal tubular dilation, cellular ischemia, interstitial inflammatory infiltration, and eventually progressive renal parenchymal atrophy and tubulointerstitial fibrosis.

• Infants/Children: Primarily congenital (UPJ obstruction), affecting approximately 1 in 100 to 500 births; more common in males.
• Young Adults: More common in females due to pregnancy and gynecological etiologies.
• Elderly: More common in males, secondary to BPH and prostate cancer.

• History of nephrolithiasis.
• Advanced age (males with BPH).
• Pregnancy.
• Pelvic or retroperitoneal malignancies.
• Recurrent urinary tract infections (UTIs).

• Vital Signs: Tachypnea, tachycardia, or hypotension (if septic); hypertension (due to fluid overload or RAAS activation).
• Palpation: Palpable flank mass (in severe hydronephrosis) or tender suprapubic globe (bladder distension in lower tract obstruction).
• Percussion: Costovertebral angle (CVA) tenderness.

• A. Clinical Assessment: Assessment of voiding patterns, pain localization, and infectious signs.
• B. Laboratory Testing: Serum chemistry, complete blood count (CBC), and urinalysis.
• C. Imaging Studies: First-line renal ultrasound; non-contrast abdominal CT for stone identification.
• D. Functional Tests: Mercaptoacetyltriglycine (MAG3) renal scan to evaluate excretion and individual kidney function.
• E. Biopsy Findings: Rarely indicated; may show interstitial fibrosis and tubular atrophy in chronic cases.
• F. Genetic Testing: Not routine, unless evaluating congenital syndromic CAKUT (Congenital Anomalies of the Kidney and Urinary Tract).
• G. Differential Diagnosis: Simple renal cysts, parapelvic cysts, pyelonephritis, or acute renal failure of pre-renal etiology.

Renal Ultrasound: Purpose: Preferred initial diagnostic modality. Typical Findings: Dilation of the renal pelvis and calyces; loss of corticomedullary differentiation in chronic disease. Clinical Importance: Highly sensitive, non-invasive, avoids radiation.
Non-Contrast CT Abdomen and Pelvis: Purpose: To identify the level and cause of obstruction. Typical Findings: Hydroureter, obstructing calculus, retroperitoneal mass, or stricture. Clinical Importance: Gold standard for identifying nephrolithiasis and extrinsic compression causes.

• Simple Renal Cysts: Located in the parenchyma, distinct from the collecting system; ultrasound shows no communication with the renal pelvis.
• Acute Pyelonephritis: Presents with fever and CVA tenderness but lacks collecting system dilation on ultrasound (unless secondary hydronephrosis is present).
• Renal Cell Carcinoma: Solid parenchymal mass on CT rather than fluid-filled calyces.

• Pyonephrosis (infected, pus-filled collecting system).
• Urosepsis.
• Chronic kidney disease (CKD).
• Renal atrophy and permanent loss of function.
• Nephrogenic diabetes insipidus.

• Short-term: Excellent if obstruction is acute and promptly relieved.
• Long-term: Chronic obstruction lasting more than several weeks can lead to permanent loss of nephrons, chronic kidney disease (CKD), or end-stage renal disease (ESRD).

• Routine monitoring of patients with chronic nephrolithiasis.
• Early medical management of BPH.
• Routine prenatal ultrasounds to detect congenital anomalies early.

The following homeopathic remedies have been historically indicated for symptoms associated with Hydronephrosis. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 Advanced Kidney & Renal Function Analyzer

Comprehensive nephrology panel. Calculates eGFR (CKD-EPI 2021 formula), CKD Stage, BUN/Creatinine Ratio, and Creatinine Clearance (Cockcroft-Gault) from a single lab panel.